These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Other 2021-006184-19 SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing’s Syndrome not-yet-due
Other 2022-000299-20 A trial of prednisolone in combination with SPI-62 or placebo in subjects with polymyalgia rheumatica (PMR) not-yet-due
Ongoing 2022-000748-32 SPI-62 as a Treatment for Hypercortisolism Related to a Benign Adrenal Tumor not-yet-due